Article

SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions

2024-09-30

Abstract excerpt

<h4>Objectives</h4> The SARS-CoV-2 JN.1 lineage emerged in late 2023 and quickly replaced the XBB lineages, becoming the predominant Omicron variant worldwide in 2024. We estimate the epidemiological impact of this SARS-CoV-2 lineage replacement in Brazil and we further assessed the cross-reactive neutralizing antibody (NAb) responses in a cohort of convalescent Brazilian patients infected during 2023. <h4>Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a358f0c6-8304-5853-a659-cb8f53603cac
DOI: 10.1101/2024.09.28.24314453

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regionsDOI 10.1101/2024.09.28.24314453Read

Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023Semantic proximity Read

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineageSemantic proximity Read

Predominance of the recombinant SARS-CoV-2 lineages XBB in Rio Grande do Sul State, Brazil: a genomic surveillance study and impact on vaccine responseSemantic proximity Read

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineageSemantic proximity Read

Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in ChinaSemantic proximity Read

SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in the northeast of BrazilSemantic proximity Read

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodiesSemantic proximity Read

Cross-neutralizing activity against SARS-CoV-2 variants in COVID-19 patients: Comparison of four waves of the pandemic in JapanSemantic proximity Read

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1Semantic proximity Read

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineagesSemantic proximity Read

Increased vaccine sensitivity of an emerging SARS-CoV-2 variantSemantic proximity Read